ALLEGAN — Perrigo Co. (Nasdaq: PRGO) Thursday announced that it is transferring the listing of its U.S. traded common stock to the New York Stock Exchange from the Nasdaq Global Select Market.

The company expects to begin trading on the NYSE on June 6 under its current stock symbol PRGO and will continue to trade on Nasdaq until the transfer takes place.

READ MORE: Here Is An Update On The Chevy Bolt Recall

“We are looking forward to listing on the NYSE as this change will provide increased visibility and enhanced services that will benefit our shareholders,” said Perrigo chairman and CEO Joseph C. Papa. “We remain committed to making quality health care more affordable for our customers and patients and continuing to increase shareholder value.” 

READ MORE: James Craig Announces Run For Governor, Begins To Campaign

Added Duncan Neiderauer, CEO of NYSE Euronext: “Perrigo and the NYSE are a perfect fit, and we’re thrilled to welcome one of the world’s leading healthcare suppliers to the world’s leading equities market. Perrigo was founded more than a century ago seeking to best serve and empower customers, continually innovate, and deliver quality products. That vision, which remains in place today, set the stage for the company’s growth and global leadership. On behalf of my NYSE Euronext colleagues, I want to thank Joe Papa and the Perrigo Board for choosing the NYSE. We look forward to building an outstanding partnership with the entire Perrigo team and the company’s shareholders.”

To celebrate the transfer, representatives of Perrigo will ring the NYSE opening bell on June 6 th at 9:30 a.m. Eastern time, which will be broadcast live on the Company’s website at

MORE NEWS: Flat Rock Sewers Free Of Gasoline From Ford Gas Leak

From its beginnings as a packager of generic home remedies in 1887, Allegan-based Perrigo has grown to become a leading global provider of over-the-counter and generic prescription pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements and active pharmaceutical ingredients. The company is the world’s largest manufacturer of OTC pharmaceutical products for the store brand market. The company’s primary markets and locations of logistics operations have evolved over the years to include the United States, Israel, Mexico, the United Kingdom, India, China and Australia.